STADA UK HOLDINGS LTD.
Get an alert when STADA UK HOLDINGS LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-08-19 (in 3mo)
Last made up 2025-08-05
Watchouts
Cash
£338K
-5.3% vs 2023
Net assets
£183M
-2.4% vs 2023
Employees
1
-50% vs 2023
Profit before tax
-£4M
+91.6% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
The Directors believe it is therefore appropriate to continue to adopt the going concern basis of accounting in preparing these financial statements. However, these conditions indicate the existence of a material uncertainty over the Company's ability to continue as a going concern, because the Directors of the Company will not have full control over any revised ownership structure and therefore do not have full knowledge of any new ultimate parent undertaking's future intentions and funding plans in relation to the Company. The financial statements do not include the adjustments that would result if the Company were unable to continue as a going concern.
-
1 PSC ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£7,709,541 | £42,232,039 | |
| Profit before tax | -£52,900,730 | -£4,465,190 | |
| Net profit | -£53,838,710 | -£4,465,190 | |
| Cash | £356,444 | £337,651 | |
| Total assets less current liabilities | £502,987,649 | £498,522,459 | |
| Net assets | £186,987,649 | £182,522,459 | |
| Equity | £186,987,649 | £182,522,459 | |
| Average employees | 2 | 1 | |
| Wages | £279,037 | £204,945 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -1.5% | 8.5% | |
| Current ratio | 1.05x | 0.17x | |
| Interest cover | -0.17x | 0.90x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101 Reduced Disclosure Framework
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The Directors believe it is therefore appropriate to continue to adopt the going concern basis of accounting in preparing these financial statements. However, these conditions indicate the existence of a material uncertainty over the Company's ability to continue as a going concern, because the Directors of the Company will not have full control over any revised ownership structure and therefore do not have full knowledge of any new ultimate parent undertaking's future intentions and funding plans in relation to the Company. The financial statements do not include the adjustments that would result if the Company were unable to continue as a going concern.”
Group structure
- STADA UK HOLDINGS LTD. · parent
- Thornton and Ross Limited 100%
- Sundrops Limited 100%
- Internis Pharmaceuticals Limited 100%
- Socialites E-Commerce Limited 100%
- Socialites Retail Limited 100%
- Fresh Vape Electronic Cigarettes Limited 100%
- Lowry Solutions Limited 100%
- Natures Aid Limited 100%
- Genus Pharmaceuticals Holdings Limited 100%
- Genus Pharmaceuticals Limited 100%
- LCM Limited 100%
- Zeroderma Limited 100%
- Britannia Pharmaceuticals Limited 100%
- Vaping Holdco Limited 100%
- Clonmel Healthcare Limited 100%
- Thornton & Ross Ireland Limited 100%
- Crosspharma Limited 100%
- STADA Corp 100%
Significant events
- “On 12 May 2025, Nidda Healthcare Holding GmbH formally and irrevocably released and discharged the Company from a portion of the £316,000,000 loan amounting to £146,000,000 resulting in a corresponding credit to the profit and loss of the Company. The remaining balance of £170,000,000 continues to be due and payable to Nidda Healthcare Holding GmbH of the £316,000,000.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COLLETT, James David | Director | 2023-09-01 | Oct 1975 | British |
| SEILER, Frank | Director | 2013-08-05 | Aug 1968 | German |
| SHAW, Craig Richard | Director | 2025-11-03 | Jan 1977 | British |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WRIGHT, Philip John | Secretary | 2013-08-05 | 2014-06-30 |
| ADAMS, Geoffrey Martin | Director | 2013-10-15 | 2018-04-06 |
| BALLARD, Peter Gavin | Director | 2013-08-05 | 2013-10-15 |
| BLYTHE, Edwin Charles | Director | 2018-12-17 | 2023-01-31 |
| GEORGE, Dieno | Director | 2018-04-06 | 2018-12-17 |
| GORE-STRACHAN, Evelyn | Director | 2013-10-15 | 2015-06-29 |
| HEYWOOD, Kathryn Maria | Director | 2023-01-31 | 2023-09-01 |
| SCARLETT-SMITH, Roger Lidderdale | Director | 2020-11-01 | 2022-10-01 |
| SLEGERS, Luc Maurice Godelieva | Director | 2014-06-02 | 2017-11-29 |
| STEPHENSON, Nigel David | Director | 2023-08-01 | 2025-07-31 |
| SYDOW, Volker | Director | 2025-06-17 | 2025-11-03 |
| WRIGHT, Philip John | Director | 2013-08-05 | 2014-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Capvest Partners Llp | Corporate entity | Significant influence | 2026-03-31 | Active |
| Cinven Partnership Llp | Corporate entity | Significant influence | 2021-10-14 | Ceased 2026-03-31 |
| Stada Arzneimittel Aktiengesellschaft | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-08-05 | Ceased 2020-11-09 |
Filing timeline
Last 20 of 79 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-01 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-05-01 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-11-05 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-04 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-06 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-10-06 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2025-10-02 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2025-10-02 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2025-08-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-19 | AA | accounts | Accounts with accounts type full | |
| 2025-08-07 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-08-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-20 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-13 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-03-12 | CH01 | officers | Change person director company with change date | |
| 2025-01-15 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-01-06 | AA | accounts | Accounts with accounts type full | |
| 2024-08-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-01 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-07-31 | AD01 | address | Change registered office address company with date old address new address |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 14
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
-5.3%
£356,444 £337,651
-
Net assets
-2.4%
£186,987,649 £182,522,459
-
Employees
-50%
2 1
-
Operating profit
+647.8%
-£7,709,541 £42,232,039
-
Profit before tax
+91.6%
-£52,900,730 -£4,465,190
-
Wages
-26.6%
£279,037 £204,945
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers